{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T00:52:09Z","timestamp":1768697529340,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2001,4,1]],"date-time":"2001-04-01T00:00:00Z","timestamp":986083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,4,1]],"date-time":"2001-04-01T00:00:00Z","timestamp":986083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2001,4,1]]},"DOI":"10.1038\/sj.bmt.1702867","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T15:51:00Z","timestamp":1031154660000},"page":"711-716","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":111,"title":["High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas"],"prefix":"10.1038","volume":"27","author":[{"given":"AK","family":"Blystad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Enblad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Kval\u00f8y","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c5","family":"Berglund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Delabie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Holte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Kvalheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Bengtsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Hagberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2001,5,4]]},"reference":[{"key":"BF1702867_CR1","first-page":"76","volume":"92","author":"C Gisselbrecht","year":"1998","unstructured":"Gisselbrecht C, Gaulard P, Lepage E et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA) Blood 1998 92: 76\u201382","journal-title":"Blood"},{"key":"BF1702867_CR2","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1182\/blood.V89.12.4514","volume":"89","author":"A Melnyk","year":"1997","unstructured":"Melnyk A, Rodriguez A, Pugh WC et al. Evaluation of the Revised European\u2013American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma Blood 1997 89: 4514\u20134520","journal-title":"Blood"},{"key":"BF1702867_CR3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/1097-0142(19890101)63:1<158::AID-CNCR2820630125>3.0.CO;2-B","volume":"63","author":"JO Armitage","year":"1989","unstructured":"Armitage JO, Greer JP, Levine AM et al. Peripheral T-cell lymphoma Cancer 1989 63: 158\u2013163","journal-title":"Cancer"},{"key":"BF1702867_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/oxfordjournals.annonc.a057673","volume":"1","author":"B Coiffier","year":"1990","unstructured":"Coiffier B, Brousse N, Peuchmaur M et al. Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d'Etude des Lymphomes Agressives) Ann Oncol 1990 1: 45\u201350","journal-title":"Ann Oncol"},{"key":"BF1702867_CR5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1182\/blood.V72.2.436.436","volume":"72","author":"SM Lippman","year":"1988","unstructured":"Lippman SM, Miller TP, Spier CM et al. The prognostic significance of the immunotype in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotype Blood 1988 72: 436\u2013441","journal-title":"Blood"},{"key":"BF1702867_CR6","doi-asserted-by":"publisher","first-page":"364","DOI":"10.7326\/0003-4819-117-5-364","volume":"117","author":"W Siegert","year":"1992","unstructured":"Siegert W, Agthe A, Griesser H et al. Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM\/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group Ann Intern Med 1992 117: 364\u2013370","journal-title":"Ann Intern Med"},{"key":"BF1702867_CR7","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1365-2141.1994.tb08308.x","volume":"87","author":"W Siegert","year":"1994","unstructured":"Siegert W, Nerl C, Engelhard M et al. Peripheral T-cell non-Hodgkin's lymphomas of low malignancy: prospective study of 25 patients with pleomorphic small cell lymphoma, lymphoepitheloid cell (Lennert's) lymphoma and T-zone lymphoma. The Kiel Lymphoma Study Group Br J Haematol 1994 87: 529\u2013534","journal-title":"Br J Haematol"},{"key":"BF1702867_CR8","first-page":"171","volume":"82","author":"F Zaja","year":"1997","unstructured":"Zaja F, Russo D, Silvestri F et al. Retrospective analysis of 23 cases with peripheral T-cell lymphoma, unspecified: clinical characteristics and outcome Haematologica 1997 82: 171\u2013177","journal-title":"Haematologica"},{"key":"BF1702867_CR9","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1200\/JCO.1998.16.8.2780","volume":"16","author":"JO Armitage","year":"1998","unstructured":"Armitage JO, Weisenburger DD . New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project J Clin Oncol 1998 16: 2780\u20132795","journal-title":"J Clin Oncol"},{"key":"BF1702867_CR10","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"NL Harris","year":"1994","unstructured":"Harris NL, Jaffe ES, Stein H et al. A revised European\u2013American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group (see comments) Blood 1994 84: 1361\u20131392","journal-title":"Blood"},{"key":"BF1702867_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1023\/A:1008249325615","volume":"8","author":"ES Jaffe","year":"1997","unstructured":"Jaffe ES, Krenacs L, Raffeld M . Classification of T-cell and NK-cell neoplasms based on the REAL classification Ann Oncol 1997 8: (Suppl. 2) 17\u201324","journal-title":"Ann Oncol"},{"key":"BF1702867_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10428199409049645","volume":"14","author":"BG Gordon","year":"1994","unstructured":"Gordon BG, Weisenburger DD, Sanger WG et al. Peripheral T-cell lymphoma in children and adolescents: role of bone marrow transplantation Leuk Lymphoma 1994 14: 1\u201310","journal-title":"Leuk Lymphoma"},{"key":"BF1702867_CR13","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood.V76.2.424.424","volume":"76","author":"JM Vose","year":"1990","unstructured":"Vose JM, Peterson C, Bierman PJ et al. Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas Blood 1990 76: 424\u2013431","journal-title":"Blood"},{"key":"BF1702867_CR14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/sj.bmt.1701596","volume":"23","author":"R Fanin","year":"1999","unstructured":"Fanin R, Ruiz-de EM, Sperotto A et al. Autologous stem cell transplantation for T and null cell CD30-positive anaplastic large cell lymphoma: analysis of 64 adult and paediatric cases reported to the European Group for Blood and Marrow Transplantation (EBMT) Bone Marrow Transplant 1999 23: 437\u2013442","journal-title":"Bone Marrow Transplant"},{"key":"BF1702867_CR15","first-page":"1860","volume":"31","author":"PP Carbone","year":"1971","unstructured":"Carbone PP, Kaplan HS, Musshoff K et al. Report of the Committee on Hodgkin's Disease Staging Classification Cancer Res 1971 31: 1860\u20131861","journal-title":"Cancer Res"},{"key":"BF1702867_CR16","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"MA Shipp","year":"1993","unstructured":"Shipp MA . A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project (see comments) New Engl J Med 1993 329: 987\u2013994","journal-title":"New Engl J Med"},{"key":"BF1702867_CR17","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1056\/NEJM199705013361804","volume":"336","author":"AM Gianni","year":"1997","unstructured":"Gianni AM, Bregni M, Siena S et al. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma (see comments) New Engl J Med 1997 336: 1290\u20131297","journal-title":"New Engl J Med"},{"key":"BF1702867_CR18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1200\/JCO.1995.13.2.359","volume":"13","author":"A Reiter","year":"1995","unstructured":"Reiter A, Schrappe M, Parwaresch R et al. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage \u2013 a report of the Berlin\u2013Frankfurt\u2013Munster Group J Clin Oncol 1995 13: 359\u2013372","journal-title":"J Clin Oncol"},{"key":"BF1702867_CR19","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1200\/JCO.1992.10.4.635","volume":"10","author":"LM DeAngelis","year":"1992","unstructured":"DeAngelis LM, Yahalom J, Thaler HT et al. Combined modality therapy for primary CNS lymphoma J Clin Oncol 1992 10: 635\u2013643","journal-title":"J Clin Oncol"},{"key":"BF1702867_CR20","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood.V77.8.1717.1717","volume":"77","author":"RJ Berenson","year":"1991","unstructured":"Berenson RJ, Bensinger WI, Hill RS et al. Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma Blood 1991 77: 1717\u20131722","journal-title":"Blood"},{"key":"BF1702867_CR21","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1089\/scd.1.1996.5.427","volume":"5","author":"G Kvalheim","year":"1996","unstructured":"Kvalheim G, Wang MY, Pharo A et al. Purging of tumor cells from leukapheresis products: experimental and clinical aspects J Hematother 1996 5: 427\u2013436","journal-title":"J Hematother"},{"key":"BF1702867_CR22","first-page":"319","volume":"9","author":"MY Wang","year":"1992","unstructured":"Wang MY, Kvalheim G, Kvaloy S et al. An effective immunomagnetic method for bone marrow purging in T cell malignancies Bone Marrow Transplant 1992 9: 319\u2013323","journal-title":"Bone Marrow Transplant"},{"key":"BF1702867_CR23","first-page":"173a (Abstr.)","volume":"94","author":"K Haider","year":"1999","unstructured":"Haider K, Zamkoff KW, Gentile TC . High dose chemotherapy (HDCT) and autologous stem cell transplant (ASCT) in peripheral T-cell lymphoma (PTCL). A single institution experience Blood 1999 94: (Suppl. 1) 173a (Abstr.)","journal-title":"Blood"},{"key":"BF1702867_CR24","doi-asserted-by":"crossref","first-page":"172a (Abstr.)","DOI":"10.1182\/blood.V94.1.172.413k17_172_178","volume":"94","author":"J Rodriguez","year":"1999","unstructured":"Rodriguez J, Khouri I, Palmer L et al. Salvage therapy with hematopoietic cell transplantation (HCT) in peripheral T-cell lymphomas (PTCL) Blood 1999 94: (Suppl. 1) 172a (Abstr.)","journal-title":"Blood"},{"key":"BF1702867_CR25","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1182\/blood.V87.4.1243.bloodjournal8741243","volume":"87","author":"R Fanin","year":"1996","unstructured":"Fanin R, Silvestri F, Geromin A et al. Primary systemic CD30 (Ki-1)-positive anaplastic large cell lymphoma of the adult: sequential intensive treatment with the F-MACHOP regimen (+\/\u2212 radiotherapy) and autologous bone marrow transplantation Blood 1996 87: 1243\u20131248","journal-title":"Blood"},{"key":"BF1702867_CR26","doi-asserted-by":"crossref","first-page":"172a (Abstr.)","DOI":"10.1182\/blood.V94.1.172.413k17_172_178","volume":"94","author":"D Kingreen","year":"1999","unstructured":"Kingreen D, Reichle A, Fetscher S et al. High-dose chemotherapy (HDCT) with autologous stem cell transplantation (PBSCT) in patients with angioimmunoblastic T-cell lymphoma (AILD) Blood 1999 94: 172a (Abstr.)","journal-title":"Blood"},{"key":"BF1702867_CR27","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","volume":"333","author":"T Philip","year":"1995","unstructured":"Philip T, Guglielmi C, Hagenbeek A et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma (see comments) New Engl J Med 1995 333: 1540\u20131545","journal-title":"New Engl J Med"},{"key":"BF1702867_CR28","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1023\/A:1008418727472","volume":"9","author":"GA Lopez","year":"1998","unstructured":"Lopez GA, Cid J, Salar A et al. Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification Ann Oncol 1998 9: 849\u2013855","journal-title":"Ann Oncol"},{"key":"BF1702867_CR29","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1182\/blood.V90.9.3727","volume":"90","author":"H Tilly","year":"1997","unstructured":"Tilly H, Gaulard P, Lepage E et al. Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome Blood 1997 90: 3727\u20133734","journal-title":"Blood"},{"key":"BF1702867_CR30","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1182\/blood.V87.7.2905.bloodjournal8772905","volume":"87","author":"DA Filippa","year":"1996","unstructured":"Filippa DA, Ladanyi M, Wollner N et al. CD30 (Ki-1)-positive malignant lymphomas: clinical, immunophenotypic, histologic, and genetic characteristics and differences with Hodgkin's disease Blood 1996 87: 2905\u20132917","journal-title":"Blood"},{"key":"BF1702867_CR31","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/0959-8049(95)00318-D","volume":"31A","author":"G Longo","year":"1995","unstructured":"Longo G, Federico M, Pieresca C et al. Anaplastic large cell lymphoma (CD30+\/Ki-1+). Analysis of 35 cases followed at GISL centres Eur J Cancer 1995 31A: 1763\u20131767","journal-title":"Eur J Cancer"},{"key":"BF1702867_CR32","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3109\/10428199609051763","volume":"22","author":"M Clavio","year":"1996","unstructured":"Clavio M, Rossi E, Truini M et al. Anaplastic large cell lymphoma: a clinicopathologic study of 53 patients Leuk Lymphoma 1996 22: 319\u2013327","journal-title":"Leuk Lymphoma"},{"key":"BF1702867_CR33","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1200\/JCO.1991.9.4.539","volume":"9","author":"JP Greer","year":"1991","unstructured":"Greer JP, Kinney MC, Collins RD et al. Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma (see comments) J Clin Oncol 1991 9: 539\u2013547","journal-title":"J Clin Oncol"},{"key":"BF1702867_CR34","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1200\/JCO.1993.11.5.937","volume":"11","author":"LN Shulman","year":"1993","unstructured":"Shulman LN, Frisard B, Antin JH et al. Primary Ki-1 anaplastic large-cell lymphoma in adults: clinical characteristics and therapeutic outcome J Clin Oncol 1993 11: 937\u2013942","journal-title":"J Clin Oncol"},{"key":"BF1702867_CR35","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3109\/10428199909145715","volume":"35","author":"R Fanin","year":"1999","unstructured":"Fanin R, Sperotto A, Silvestri F et al. The therapy of primary adult systemic CD30-positive anaplastic large cell lymphoma: results of 40 cases treated in a single center Leuk Lymphoma 1999 35: 159\u2013169","journal-title":"Leuk Lymphoma"},{"key":"BF1702867_CR36","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1200\/JCO.1997.15.6.2296","volume":"15","author":"SM Ansell","year":"1997","unstructured":"Ansell SM, Habermann TM, Kurtin PJ et al. Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma J Clin Oncol 1997 15: 2296\u20132301","journal-title":"J Clin Oncol"},{"key":"BF1702867_CR37","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1182\/blood.V87.3.1045.bloodjournal8731045","volume":"87","author":"F d'Amore","year":"1996","unstructured":"d'Amore F, Johansen P, Houmand A et al. Epstein\u2013Barr virus genome in non-Hodgkin's lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO Blood 1996 87: 1045\u20131055","journal-title":"Blood"},{"key":"BF1702867_CR38","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/sj.bmt.1701990","volume":"24","author":"A Blystad","year":"1999","unstructured":"Blystad A, Kvalheim G, Torlakovic E et al. High-dose therapy supported with immunomagnetic purged autologous bone marrow in high-grade B cell non-Hodgkin's lymphoma Bone Marrow Transplant 1999 24: 865\u2013872","journal-title":"Bone Marrow Transplant"},{"key":"BF1702867_CR39","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1056\/NEJM199111283252201","volume":"325","author":"JG Gribben","year":"1991","unstructured":"Gribben JG, Freedman AS, Neuberg D et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma (see comments) New Engl J Med 1991 325: 1525\u20131533","journal-title":"New Engl J Med"},{"key":"BF1702867_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1023\/A:1008339921975","volume":"11","author":"HC Schouten","year":"2000","unstructured":"Schouten HC, Kvaloy S, Sydes M et al. The CUP trial: a randomized study analyzing the efficacy of high dose therapy and purging in low-grade non-Hodgkin's lymphoma (NHL) Ann Oncol 2000 11: 91\u201394","journal-title":"Ann Oncol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1702867","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702867.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1702867.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T22:15:49Z","timestamp":1648073749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1702867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4,1]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2001,4,1]]}},"alternative-id":["BF1702867"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1702867","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,4,1]]},"assertion":[{"value":"10 July 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2001","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2001","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}